Immuto Scientific Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Immuto Scientific operates in biotechnology research, focusing on target discovery by uncovering structural fingerprints that differentiate diseased from healthy states. Its therapeutic discovery arm aims to develop first-in-class therapeutics that target disease-specific changes in cell-surface proteins. The company leverages AI-enabled target discovery and epitope identification to identify novel surface protein conformations from patient-derived samples, with an initial emphasis on oncology.

Based in Cambridge, Massachusetts, Immuto originated as a spin-out from the University of Wisconsin–Madison and positions itself as a specialized provider within the biotechnology research ecosystem. The company collaborates with external partners to identify cancer-specific targets on cell surfaces, exemplified by a September 2025 collaboration with Daiichi Sankyo Co., Ltd. Its market focus is on enabling safer, more precise therapies through disease-agnostic target discovery, targeting pharmaceutical and biotech development programs.

Get verified Immuto Scientific emails free

Company overview Employee directory